	US 11,925,622 B2
	Role of novel carbazole linked 1, 2, 3- triazole analogs in alleviating methylglyoxal-mediated late diabetic vascular complications
Humera Jahan, Karachi (PK); Mohammad Iqbal Choudhary, Karachi (PK); Nimra Naz Siddiqui, Karachi (PK); Fatima Z. Basha, Karachi (PK); and Shazia Iqbal, Karachi (PK)
Filed by Humera Jahan, Karachi (PK); Mohammad Iqbal Choudhary, Karachi (PK); Nimra Naz Siddiqui, Karachi (PK); Fatima Z. Basha, Karachi (PK); and Shazia Iqbal, Karachi (PK)
Filed on Aug. 20, 2021, as Appl. No. 17/408,006.
Prior Publication US 2023/0054099 A1, Feb. 23, 2023
Int. Cl. A61K 31/4196 (2006.01); A61K 31/403 (2006.01); A61K 31/4439 (2006.01); A61P 9/12 (2006.01)

CPC A61K 31/4196 (2013.01) [A61K 31/403 (2013.01); A61K 31/4439 (2013.01); A61P 9/12 (2018.01)]

3 Claims

1. A method for reducing the development of diabetes-associated late vascular impairment diabetic atherogenesis progression comprising administration to diabetic patients in need for such treatment, an effective dose of a carbazole-linked 1,2,3-triazole compounds, in a pharmaceutical formulation.